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Clostridioides difficile Luxs 
mediates inter-bacterial 
interactions within biofilms
Ross t. slater1, Lucy R. Frost1, sian e. Jossi  1, Andrew D. Millard2 & Meera Unnikrishnan1
the anaerobic gut pathogen, Clostridioides difficile, forms adherent biofilms that may play an 
important role in recurrent C. difficile infections. the mechanisms underlying C. difficile community 
formation and inter-bacterial interactions are nevertheless poorly understood. C. difficile produces 
AI-2, a quorum sensing molecule that modulates biofilm formation across many bacterial species. We 
found that a strain defective in LuxS, the enzyme that mediates AI-2 production, is defective in biofilm 
development in vitro. Transcriptomic analyses of biofilms formed by wild type (WT) and luxS mutant 
(luxS) strains revealed a downregulation of prophage loci in the luxS mutant biofilms compared to the 
WT. Detection of phages and eDNA within biofilms may suggest that DNA release by phage-mediated 
cell lysis contributes to C. difficile biofilm formation. In order to understand if LuxS mediates C. difficile 
crosstalk with other gut species, C. difficile interactions with a common gut bacterium, Bacteroides 
fragilis, were studied. We demonstrate that C. difficile growth is significantly reduced when co-cultured 
with B. fragilis in mixed biofilms. Interestingly, the absence of C. difficile Luxs alleviates the B. fragilis-
mediated growth inhibition. Dual species RNA-sequencing analyses from single and mixed biofilms 
revealed differential modulation of distinct metabolic pathways for C. difficile WT, luxS and B. fragilis 
upon co-culture, indicating that AI-2 may be involved in induction of selective metabolic responses in 
B. fragilis. overall, our data suggest that C. difficile LuxS/AI-2 utilises different mechanisms to mediate 
formation of single and mixed species communities.
Clostridiodes difficile (Clostridium difficile), an anaerobic, opportunistic pathogen, is the causative agent of C. difficile 
infection (CDI), a debilitating condition with symptoms ranging from mild diarrhoea to severe pseudomembra-
nous colitis. ~453,000 cases of CDI were reported in the United States in 20111 and there have been increasing 
reports of CDI from different parts of the world2–4. Treatment of CDI is complicated by the fact that 20–36% of 
cases experience recurrence, relapsing after completion of initial treatment5. CDI is primarily a hospital-acquired 
infection with the elderly being at highest risk6 and has been associated with the disruption of the gut microbiota 
as a result of the use of broad-spectrum antibiotics. However, more recently, there has been a reported increase 
in community-acquired cases where patients do not have the typical risk factors such as antibiotic exposure or 
recent hospitalisation7.
Colonisation of C. difficile and development of CDI is influenced by composition of the native gut microbi-
ota. Broadly, Bacteroides, Prevotella, Bifidobacterium, Enterococcaceae and Leuconostocaceae spp. correlate nega-
tively8–10, and Lactobacilli, Aerococcaceae, Enterobacteriaceae, and Clostridium correlate positively to C. difficile 
colonisation and disease8,10–13. While mechanisms underlying colonisation resistance are not entirely clear, some 
pathways have been described recently. Secondary bile acids produced by bacteria like Clostridium scindens can 
inhibit C. difficile growth, while other bile acids such as chenodeoxycholate can inhibit spore germination14–16. 
Studies have shown that the ability of C. difficile to utilise metabolites produced by the gut microbiota or mucosal 
sugars such as sialic acid promote C. difficile expansion in the gut17,18. However, gaps still remain in our under-
standing of C. difficile interactions with members of the gut microbiota.
Research into CDI has primarily focused on the action of two large toxins19,20 that cause tissue damage, neu-
trophil recruitment and a severe inflammatory response21. More recently, a number of factors have been shown 
to influence adhesion of C. difficile to host cells and early colonisation, including cell wall proteins, adhesins and 
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flagella22–26. C. difficile also produces biofilms that confer increased resistance to antibiotics27–29 and have recently 
shown to be associated with C. difficile infection in vivo, in close association with other commensal gut species30.
Formation of adherent communities within the gut requires communication between bacteria. For many 
species, quorum sensing (QS) is important for the construction and/or dispersal of biofilm communities31, with 
bacteria utilising diverse QS systems31,32. Many bacteria possess the metabolic enzyme LuxS, which is involved 
in the detoxification of S-adenoslylhomocysteine during the activated methyl cycle. Whilst catalysing the reac-
tion of S-ribosylhomocysteine to homocysteine, LuxS produces the bi-product 4,5-dihydroxy-2,3-pentanedione 
(DPD). DPD is an unstable compound that spontaneously cyclises into several different forms. These ligands are 
collectively known as autoinducer-2 (AI-2), a group of potent, cross-species QS signalling molecules33. In many 
bacteria, including C. difficile, AI-2 plays a role in biofilm formation, with luxS mutants showing a defect during 
biofilm formation and development27,34–39. The precise mode of action for LuxS in C. difficile has remained elusive 
as a result of conflicting studies and the lack of a clear receptor for AI-234,40,41.
Here we investigate the role of LuxS within C. difficile and mixed biofilm communities. Interestingly, we find 
that C. difficile LuxS/AI-2 mediates the induction of two putative C. difficile R20291 prophages within C. difficile 
biofilms. In mixed biofilms, we show that in the presence of B. fragilis, a gut bacterium, C. difficile growth is 
inhibited and this inhibition is alleviated in the absence of LuxS. Dual species transcriptomics show that distinct 
metabolic pathways are triggered in mixed cultures with the wild type (WT) and luxS mutant C. difficile strains.
Results
LuxS mediates biofilm formation in vitro. We previously reported that a R20291 C. difficile luxS mutant 
(luxS) was defective in biofilm formation as measured by crystal violet (CV) staining27. However, in our subse-
quent studies, although we see a reduction in biofilms at 24 h, we observe a high variability in the WT biofilms 
formed at 24 h and in the reduction in the luxS mutant between experiments (Fig. 1A). Nevertheless, the biofilm 
defect for luxS was very consistent at later time points (72 h) (Fig. 1A,B). In spite of differences in total biofilm 
content, colony counts from the WT and luxS biofilms were similar at both time points (Fig. 1C). There were also 
no differences in the spore content of WT and luxS biofilms (~0.003% at 24 h and ~0.1% at 72 h) (Fig. S1).
To determine if AI-2 signalling is involved in biofilm formation, we first performed an AI-2 assay from both 
planktonic and biofilm supernatants as described by Carter et al. 2005 (Fig. S2A). AI-2 is produced maximally 
in mid-log and stationary phases as previously reported40. The WT strain produced less AI-2 in 24 h biofilms 
compared to log phase culture, while the luxS strain did not produce AI-2 as expected (Fig. S2B). To study if 
the reduction in biofilm formation in luxS could be complemented by chemically synthesised 4,5-dihydroxy-2, 
3-pentanedione (DPD), the precursor of AI-2, was supplemented in the culture medium. Whilst high concentra-
tions (>1000 nM) appeared to have only a partial effect on biofilm formation (Fig. S3), a concentration of 100 nM 
was capable of restoring the WT phenotype (Fig. 1D), indicating that AI-2 may be involved in signalling within 
C. difficile biofilms.
RNA-seq analysis reveals LuxS-mediated prophage induction. To investigate mechanism of action 
of LuxS/AI-2 in C. difficile, transcriptional profiles of C. difficile WT and luxS strains planktonically cultured 
(OD600 0.8 in BHI) were first compared using RNA-seq. However, surprisingly, no differential transcriptional 
changes were observed (Accession number E-MTAB-7486). Following this, an RNA-seq analysis was performed 
with total RNA isolated from C. difficile WT and luxS biofilms grown in BHIS +0.1 M glucose [(BHIS-G) con-
ditions used for biofilm assays in Fig. 1] for 18 h (Accession number E-MTAB-7523). Both strains show similar 
planktonic culture growth rates in BHIS-G as reported previously27.
The DESeq2 variance analysis package42 was used to identify genes that were differentially expressed in luxS 
≥1.6-fold relative to the WT strain, with a p -adjusted value ≤0.05. This pairwise analysis identified 21 dif-
ferentially expressed genes (Fig. 2A,C) (Table 1). Interestingly, all 18 down-regulated genes correspond to two 
prophage regions located within the C. difficile R20291 genome, CDR20291_1415–1464 and CDR20291_1197–
1226 (Fig. 2B), as identified using the online phage search tool, Phaster43,44. A Fisher’s exact test (p-value < 0.001 
for both prophage regions) further confirmed an enrichment of differently regulated genes in prophage regions. 
There were only three genes upregulated in the luxS biofilms compared to the WT; two of these were involved in 
trehalose utilisation, while the third was a phosphotransferase system glucose-specific transporter.
To demonstrate the presence of phage in the biofilm, cell-free supernatants were treated with DNase, before a 
subsequent DNA extraction was performed. As the bacterial cells were already removed, only DNA within intact 
bacteriophages would be protected from DNase. A 16S rRNA gene PCR was performed to confirm digestion of 
all free extracellular genomic DNA from the biofilm (Fig. 3A). PCRs with primers corresponding to genes specific 
to each prophage, confirmed that the DNA extracted had come from the phage (Fig. 3B). Since cell lysis is linked 
to phage release, we quantified and compared the total extracellular DNA (eDNA) content of luxS mutant and 
WT biofilms. The WT biofilms contained more eDNA compared to the luxS mutant at 24 h and 72 h (Fig. 3C). 
Overall, these data suggest that AI-2 may play a role in inducing prophages in C. difficile biofilms, which leads to 
phage-mediated host cell lysis and eDNA generation, which may contribute to subsequent biofilm accumulation.
C. difficile is inhibited when cultured with B. fragilis in mixed biofilms. Given the high microbial 
density within the gut, C. difficile likely needs to interact with other members of the gut microbiota to establish 
itself within this niche. As an inter-species signalling function has been previously proposed for AI-245, we sought 
to investigate the interactions between a gut-associated Bacteroides spp and C. difficile. We examined C. difficile 
interactions with Bacteriodes fragilis, a gut commensal and pathogen, that has been previously reported to nega-
tively correlate with CDI infections46.
C. difficile formed significantly more biofilms in vitro compared with B. fragilis in monocultures, as meas-
ured by CV staining (Fig. 4A). When both organisms were co-cultured, less biofilm was formed compared to 
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C. difficile monoculture (Fig. 4A). Both B. fragilis and C. difficile grow well, although with slightly different growth 
rates, in BHIS-G (Fig. S4). To investigate the impact of co-culturing on both C. difficile and B. fragilis, bacterial 
numbers (CFU/ml) were determined from monoculture and mixed biofilms (Fig. 4B). Colony counts obtained 
from the mono and co-culture biofilms confirmed that B. fragilis was a poor biofilm producer when cultured 
alone. Interestingly, when both species were co-cultured, the CFU/ml for C. difficile was significantly reduced, 
and the CFU/ml of B. fragilis was significantly higher. This reduction of colony counts of C. difficile was observed 
at both 24 h (Fig. 4B) and 72 h (Fig. S5). AI-2 production from single and mixed biofilms was also quantitated. 
We observed no production of AI-2 by B. fragilis, and a reduction of AI-2 production by the mixed biofilms 
compared with the WT C. difficile biofilms (Fig. S6). C. difficile spore measurements from the mixed biofilms 
indicate that while the percentage of spores is higher (2%) due to the decrease in C. difficile numbers, there was no 
Figure 1. LuxS biofilm defect is reversed by addition of DPD. (A) WT and LuxS biofilms were grown for 24 h or 
72 h and stained with 0.2% CV, followed by measuring OD570, N = 5. (B) Representative pictures of crystal violet 
stained C. difficile WT and luxS biofilms after 72 h. (C) Colony counts (vegetative cells) from biofilms (N = 7) 
after 24 h and 72 h. (D) The AI-2 precursor, DPD, was exogenously supplemented to LuxS at a concentration 
of 100 nM, followed by biofilm staining and quantitation with 0.2% CV after 72 h (N = 4). Error bars indicate 
SD, *p < 0.05, **p < 0.01, ***p < 0.001 as determined by Student’s t-test or by Mann-Whitney U test, ns- not 
significant.
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increase in the actual spore numbers (Fig. S7). These data suggest that the presence of B. fragilis in biofilms results 
in inhibition of C. difficile growth.
To understand if the inhibitory effect was due to a factor secreted by B. fragilis, C. difficile and B. fragilis were 
co-cultured under planktonic conditions for 6 h and 10 h (Fig. 4C). However, there were no significant differences 
in C. difficile bacterial numbers between mono and co-culture. Additionally, supplementing biofilms with B. 
fragilis planktonic or biofilm culture supernatants did not cause C. difficile growth inhibition (Fig. S8), indicat-
ing that the observed inhibitory effects were specific to adherent biofilms i.e. when they are in close proximity 
to each other.
Luxs is involved in the B. fragilis inhibition of C. difficile. To study the role of LuxS in C. difficile-B. 
fragilis interactions, WT C. difficile and luxS strains were co-cultured with B. fragilis in mixed biofilms. CV stain-
ing of biofilms showed that there was less luxS biofilm formed compared to the WT when co-cultured with B. 
fragilis (Fig. 5A). While colony counts of C. difficile in monocultures were similar for both WT and luxS strains 
(Fig. 1B), when co-cultured with B. fragilis the bacterial counts for both C. difficile strains were significantly 
reduced, although the reduction was significantly higher for the WT than luxS (Fig. 5B). Colony counts for B. fra-
gilis increased significantly during co-culture, with similar levels observed in both co-culture conditions (Fig. 5B). 
There was no increase in the spore numbers in the luxS in mixed biofilms (Fig. S7). These data suggest that AI2/
LuxS is involved in mediating the B. fragilis-induced inhibition of C. difficile, when they are within adherent 
communities.
Figure 2. Down-regulation of prophage genes in the C. difficile luxS mutant. (A) Pairwise analysis identified 
21 differentially expressed genes in luxS (red points). All 18 down-regulated genes clustered into two regions. 
(B) Three prophage regions are identified in the C. difficile genome using Phaster. Regions 2 and 3 were down 
regulated in luxS. (C) Heat map representation of the genes that were differentially expressed in luxS, red and 
green indicate down- and up-regulation respectively when compared to WT. 18 prophage genes were found to 
be down-regulated in luxS relative to WT, whilst two genes involved in trehalose metabolism were up-regulated 
in luxS relative to WT. Data shown is the mean of 3 independent experiments in triplicates. Differential 
expression was defined as ≥1.6-fold change relative to WT with an adjusted p-value ≤ 0.05.
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No Gene ID log2 FoldChange Gene annotation
1 CDR20291_1206 −0.994213972 hypothetical protein
2 CDR20291_1207 −1.059645046 hypothetical protein
3 CDR20291_1208 −1.227114763 hypothetical protein
4 CDR20291_1210 −1.08584066 hypothetical protein
5 CDR20291_1211 −1.0763802 hypothetical protein
6 CDR20291_1212 −1.009946545 phage cell wall hydrolase
7 CDR20291_1214 −1.09972952 phage protein
8 CDR20291_1215 −1.038498251 phage protein
9 CDR20291_1216 −1.047731727 phage protein
10 CDR20291_1217 −0.999294901 phage tail fiber protein
11 CDR20291_1218 −0.898724949 hypothetical protein
12 CDR20291_1425 −0.928686375 virulence-associated protein e
13 CDR20291_1432 −1.243533992 phage terminase large subunit
14 CDR20291_1433 −1.154529376 phage portal protein
15 CDR20291_1436 −1.156306053 phage major capsid protein
16 CDR20291_1442 −1.085573967 phage protein
17 CDR20291_1444 −1.257181603 phage protein
18 CDR20291_1449 −1.008627768 phage tail tape measure protein
19 CDR20291_2554 0.895993497 PTS system glucose-specific transporter subunit IIA
20 CDR20291_2927 1.587075038 cellobiose-phosphate degrading protein
21 CDR20291_2930 1.444846424 trehalose-6-phosphate hydrolase
Table 1. Genes up- and down-regulated in luxS relative to the WT C. difficile Note: P-adjusted value ≤ 0.05.
Figure 3. Presence of phage and eDNA in C. difficile biofilms. The phage origin of DNA isolated from WT 
biofilms was confirmed by PCR, using primers for 16S (A) and two phage genes (CDR20291_1436 and 
CDR20291_1208) (B). The negative controls were run on a different part of the same gel. The gel pictures 
were trimmed with no adjustment to the intensities. WT-1–3 are three biological replicates. (C) Total eDNA 
extracted from the WT and luxS mutant biofilms after 24 h and 72 h, normalised to the biofilm biomass. N = 3, 
****p < 0.0001 as determined by Mann-Whitney U test.
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Dual species RNA-seq analysis shows altered metabolism in C. difficile and B. fragilis in the 
absence of Luxs. To investigate mechanisms underlying the C. difficile inhibition mediated by B. fragilis, we 
performed an RNA-seq analysis to compare biofilm monocultures of C. difficile WT, luxS or B. fragilis with mixed 
Figure 4. B. fragilis mediated inhibition of C. difficile in mixed biofilms. (A) Biofilm of C. difficile, B. fragilis and 
both species co-cultured (mixed) were grown for 24 h and stained with 0.2% CV, followed by measuring OD570. 
(B) Colony counts for both C. difficile (vegetative cells) and B. fragilis from mono and co-culture biofilms after 
24 h. (C) Colony counts for both C. difficile (vegetative cells) and B. fragilis from mono and co-culture during 
planktonic growth. Data shown is the mean of 3 independent experiments in triplicates and error bars indicate 
SD, **p < 0.005, ****p < 0.0001 as determined by one-way ANOVA, Tukey’s multiple comparison test, ns -not 
significant (significant differences were determined for C. difficile or B. fragilis mean CFU counts between single 
and mixed biofilms).
Figure 5. B. fragilis-mediated inhibition of C. difficile is more prominent for WT than LuxS. (A) Biofilms for 
mono and co-cultures of C. difficile WT and luxS with B. fragilis were grown for 24 h and stained with 0.2% 
CV and were quantified using a spectrophotometer OD570. (B) Colony counts for C. difficile WT, C. difficile 
luxS (vegetative cells) during co-culture with B. fragilis were performed at 24 h. Data shown is the mean of 3 
independent experiments in triplicates and error bars indicate SD, **p < 0.01, ***p < 0.001 as determined by 
one-way ANOVA, Tukeys multiple comparison test (significant differences were determined for C. difficile or  
B. fragilis mean CFU counts between single and mixed biofilms).
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biofilm co-cultures of C. difficile WT or luxS with B. fragilis (Accession number E-MTAB-7523). Differentially 
expressed genes were defined as having ≥1.6-fold relative to their respective control (mono-cultures of either 
B. fragilis or C. difficile WT), with an adjusted p-adjusted value ≤ 0.05.
We compared the expression profiles of C. difficile WT biofilms to C. difficile WT-B. fragilis mixed biofilms and 
C. difficile luxS biofilms to C. difficile luxS-B. fragilis mixed biofilms. A total of 45 genes were up-regulated (21) or 
down-regulated (24) in C. difficile WT (Fig. 6, Table 2), while 69 genes were differentially expressed in C. difficile 
luxS of which 34 were down-regulated and 35 up-regulated, during co-culture with B. fragilis (Fig. 6A, Table 3).
Eight up-regulated genes were specific to C. difficile WT co-culture (Table 2). Of these, four genes involved 
in fatty acid biosynthesis and metabolism: fabH encoding 3-oxoacyl-[acyl-carrier protein] synthase III, fabK 
encoding trans-2-enoyl-ACP reductase, accC encoding a biotin carboxylase (acetyl-CoA carboxylase subu-
nit A), and accB encoding a biotin carboxyl carrier protein of acetyl-CoA carboxylase (Table 2). 11 genes were 
down-regulated exclusively in WT however, these genes do not coincide with a specific metabolic pathway.
18 up-regulated genes were specific to luxS in co-culture (Table 3). These include a putative homocyst-
eine S-methyltransferase, a putative osmoprotectant ABC transporter, substrate binding/ permease protein, 
ribonucleoside-diphosphate reductase alpha chain (nrdE) and two genes from the trehalose operon: a PTS system 
II ABC transporter, and trehalose-6-phosphate hydrolase (treA). 24 genes were down-regulated (Table 3), which 
include 3 genes involved in thiamine metabolism thiD, thiK and thiE1, (CDR20291_1497, CDR20291_1498 
and CDR20291_1499 respectively) which encode a putative phosphomethylpyrimidine kinase, 4-methyl-5
-beta-hydroxyethylthiazole kinase and thiamine-phosphate pyrophosphorylase respectively.
A total of 26 genes were differentially expressed in both C. difficile WT and C. difficile luxS when co-cultured 
with B. fragilis (Fig. 6A, Table S1). These include six up-regulated genes (accB, abfH, abfT, abfD, sucD and cat1) 
involved in carbon and butanoate metabolism, with cat1, which encodes succinyl-CoA:coenzyme A transferase, 
being the highest up-regulated gene for both C. difficile strains.
When C. difficile WT-B. fragilis mixed biofilms and luxS-B. fragilis mixed biofilms were compared to B. fragilis 
single biofilms, in contrast, a higher number of genes (266) were differentially expressed in B. fragilis when 
co-cultured with C. difficile (WT and luxS) (Table S4, Fig. 6B). A total of 114 B. fragilis genes were found to be spe-
cific to C. difficile WT co-culture, with 56 of these up-regulated and 58 down-regulated (Table S2). Similarly, 91 
genes were found to be specific to C. difficile luxS co-culture, with 56 of these up-regulated and 35 down-regulated 
(Table S3). Although distinct B. fragilis expression profiles were observed with the WT and luxS (Fig. 6B), there 
were no clear pathways identified in the datasets.
Whilst the highest up-regulated gene in both WT and LuxS co-cultures encodes a putative virus attachment 
protein, no other viral genes were shown to be up-regulated (Table S4). Genes encoding iron containing pro-
teins desulfoferrodoxin and rubrerythrin were highly up-regulated in both conditions. Interestingly, multiple 
copies of fecR, a key regulator for the ferric citrate transport system47, and ferrous iron transport protein B were 
also up-regulated. Additionally, a number of other metabolic pathways were up-regulated, including four genes 
(encoding 3-isopropylmalate dehydratase small subunit, 3-isopropylmalate dehydrogenase, Galactokinase 
and 3-isopropylmalate dehydratase large subunit) involved in valine, leucine and isoleucine biosynthesis and 
C5-branched dibasic acid metabolism. It should be noted that many of the up-regulated genes were hypothetical 
proteins of unknown function. Similarly, several metabolic pathways were down-regulated in both co-culture 
conditions. These include six genes involved in carbon metabolism, four genes involved in alanine, aspartate and 
glutamate metabolism, and four genes involved in the biosynthesis of amino acids, although these appear to be 
single genes rather than specific pathways.
Discussion
Inter-bacterial interactions within gut communities are critical in controlling invasion by intestinal pathogens. 
Quorum sensing molecules such as AI-2 are instrumental in bacterial communication, especially during forma-
tion of bacterial communities31,36,37,48–50. C. difficile produces AI-2, although the mechanism of action of LuxS/
AI-2 in C. difficile, particularly within a biofilm community is unclear. We report here that the C. difficile LuxS/
AI-2 plays an important role in the formation of single and multi-species communities. In C. difficile biofilms, 
LuxS mediates the induction of prophages, which likely contributes to the biofilm structure. Whereas, in a mixed 
biofilm of C. difficile and the intestinal commensal and pathogen, B. fragilis, LuxS likely triggers the induction of 
differential metabolic responses in B. fragilis, that leads to growth inhibition of C. difficile. To our knowledge, this 
is the first time dual species RNA-seq51 has been applied to analyse interactions between anaerobic gut bacteria 
in an adherent biofilm community.
Bacterial biofilms contain a number of extracellular components that make up their complex structure includ-
ing extracellular DNA (eDNA), a key component that binds together bacteria within a community. Autolysis is a 
common mechanism by which eDNA is released from bacterial cells52. In bacteria such as Staphylococcus aureus 
and Pseudomonas aeruginosa, eDNA is generated through the lysis of subpopulations within a biofilm, under the 
control of quorum sensing52–55. In C. difficile luxS mutant (luxS) biofilms, we observe reduced induction of two 
C. difficile prophages compared with the WT. These phage loci were conserved in several C. difficile strains with 
the Region 2 encoding a phiC2-like, phi-027 phage56–58. Given that it has previously been shown that eDNA is 
a major component of C. difficile biofilms27,30, it is likely that phage-mediated bacterial cell lysis and subsequent 
DNA release help build a biofilm. Indeed, given the detection of eDNA in the luxS biofilms, there are likely other 
unknown eDNA release mechanisms during C. difficile biofilm formation.
Phages are also known to control biofilm structure in some organisms: a filamentous phage of P. aeruginosa 
was reported to be a structural component of the biofilm59 and an AI-2 induced phage mediated the dispersal of 
Enterococcus faecalis biofilms60. Although attempts to visualise phages from C. difficile biofilms with transmission 
electron microscopy (data not shown) were unsuccessful, we cannot rule out the possibility that C. difficile phages 
may directly influence the biofilm structure. While the precise mechanisms by which LuxS/AI-2 controls phage 
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induction are yet to be elucidated, AI-2 appears to be signalling through a yet unidentified AI-2 receptor in C. 
difficile. Phage-mediated control of biofilms may in part explain the variation observed in biofilm formation 
between different C. difficile strains61.
The human gut hosts a variety of bacterial species, which compete or coexist with each other. It is likely that 
the bacteria occupying this niche form multi-species bacterial communities in association with the mucus layer. 
Interactions within such communities are important in gaining a better understanding of phenomena such as 
Figure 6. Dual species RNA-seq shows modulation of metabolic pathways in C. difficile WT, luxS and B. fragilis. 
Heat maps showing clustering of up- and down-regulated genes in (A) C. difficile WT and luxS co-cultured with 
B. fragilis compared to C. difficile WT mono-culture, and in (B) B. fragilis co-cultured with C. difficile WT and 
luxS compared to B. fragilis mono-culture. Red indicates genes that are down-regulated, whilst green indicates 
genes that are up-regulated.
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‘colonisation resistance’ which prevents pathogens such as C. difficile from establishing an infection14. Whilst 
sequencing studies have identified members of the Bacteroides genus as being associated with gut colonisation 
resistance to C. difficile, the mechanisms have remained elusive10. A recent study demonstrated that production 
of the enzyme: bile salt hydrolase, is responsible for the inhibitory effect of B. ovatus on C. difficile62. This study 
reported that in the presence of bile acids, cell free supernatants for B. ovatus were capable of inhibiting the 
growth of C. difficile whereas in the absence of bile acids, C. difficile growth was promoted. Since bile acids are not 
supplemented into our media, a different mechanism is likely responsible for B. fragilis mediated inhibition of C. 
difficile. Also, the growth restraining effects of B. fragilis on C. difficile were evident only within mixed biofilms, 
not in planktonic culture or with culture supernatants. While it is likely that cell-cell contact is essential for the 
inhibitory effect, we cannot exclude involvement of an inhibitory secreted molecule that accumulates to a higher 
concentration within a biofilm environment, or that B. fragilis has a competitive growth advantage in a biofilm 
environment.
A dual species RNA-seq analysis performed to understand the interactions between the two bacterial species, 
showed that largely all the differentially expressed genes mapped to distinct metabolic pathways. Overall, a higher 
number of genes were modulated in B. fragilis as compared to C. difficile strain during co-culture, which is in line 
with the growth characteristics observed. Carbon and butanoate metabolism pathways were induced in C. difficile 
strains in response to co-culture (accB, abfH, abfT, abfD, sucD and cat1). An up-regulation of the succinate utili-
sation genes was also recently reported in C. difficile 630 microfermenter biofilm cells as compared to planktonic 
cells63. As B. fragilis is known to produce succinate64, it is likely that the upregulation in these pathways results 
from the increased levels of succinate in the culture medium. However, since gut microbiota-produced succinate 
promotes C. difficile growth in vivo17, it is unlikely that these changes are directly responsible for the observed 
inhibition of C. difficile. However, bacteria utilise carbohydrates in a sequential manner65. Consistent with this, 
we observed a down-regulation of genes important for the utilisation of pyruvate such as bcd2 and idhA encoding 
for butyryl-CoA dehydrogenase and (r)-2-hydroxyisocaproate dehydrogenase respectively. A down-regulation 
of sugar fermentation pathway genes was also observed by Poquet et al. in single species C. difficile biofilms com-
pared to planktonic cultures63. Such a shift in metabolism could allow B. fragilis to fully consume other metabo-
lites, and thus enabling it to outcompete C. difficile.
Additionally, it is interesting to note that a number of copies of the ferric citrate transport system regulator, 
fecR, are up-regulated in B. fragilis during C. difficile co-culture. The ferric citrate transport system is an iron 
uptake system that responds to the presence of citrate47,66. Analysis of the C. difficile genome using BLAST (NCBI) 
showed that C. difficile does not possess this iron uptake system. Given the evidence that ferric citrate is an iron 
source in the gut47,67, B. fragilis may have an advantage over C. difficile in sequestering iron, and thus preventing 
C. difficile colonisation. Although the clear modulation of metabolic pathways strongly suggest a competitive 
advantage of B. fragilis over C. difficile, it is possible that the genes with unknown functions that are differentially 
expressed in B. fragilis (Table S1), encode pathways for the production of yet to be identified small inhibitory 
molecules.
The LuxS/AI-2 quorum sensing system is known to have a cross-species signalling role in many bacteria45,68. 
While all sequenced C. difficile strains produce AI-2, only selected strains of B. fragilis have the ability to produce 
AI-269. A recent study showed that Ruminococcus obeuem inhibited Vibrio cholerae in the gut via LuxS/AI-2 
mediated downregulation of V. cholerae colonisation factors70. Also, AI-2 produced by engineered E. coli was 
No Gene ID log2FoldChange Gene Annotation
1 CDR20291_0194 1.3822081 10 kDa chaperonin
2 CDR20291_1016 1.7087847 glycerol-3-phosphate acyltransferase PlsX
3 CDR20291_1017 1.7011992 3-oxoacyl-ACP synthase III
4 CDR20291_1018 1.2469326 trans-2-enoyl-ACP reductase
5 CDR20291_1337 1.3290499 transcriptional regulator
6 CDR20291_1861 1.412304 biotin carboxylase acetyl-CoA carboxylase subunit A
7 CDR20291_2027 1.6309458 2-nitropropane dioxygenase
8 CDR20291_3225 1.0229025 formate/nitrite transporter
9 CDR20291_0363 −1.377088 radical SAM protein
10 CDR20291_0364 −1.003595 hypothetical protein
11 CDR20291_0365 −1.461207 (R)-2-hydroxyisocaproate dehydrogenase
12 CDR20291_0659 −1.248536 radical SAM protein
13 CDR20291_1271 −1.15672 hypothetical protein
14 CDR20291_1309 −1.208811 phosphohydrolase
15 CDR20291_1400 −1.833327 imidazole glycerol phosphate synthase subunit HisH
16 CDR20291_1834 −1.411634 ethanolamine/propanediol ammonia-lyase heavy chain
17 CDR20291_2416 −1.231651 hypothetical protein
18 CDR20291_2417 −1.574982 hypothetical protein
19 CDR20291_2610 −1.046807 two-component sensor histidine kinase
Table 2. Genes up and down-regulated in WT during co-culture with B. fragilis relative to the WT C. difficile 
monoculture. Note: P-adjusted value ≤ 0.05.
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reported to influence firmicutes/bacteroidetes ratios in microbiota treated with streptomycin71. Our data show 
the involvement of LuxS/AI-2 in the B. fragilis-mediated C. difficile growth inhibition. As the B. fragilis strain used 
in this study does not produce AI-2, it is likely that B. fragilis responds differentially to AI-2 produced by C. diffi-
cile. Similar to the WT, most transcriptional changes were in metabolic pathways, although specific sets of genes 
were modulated in the luxS mutant. Modulation of prophage genes was not seen, unlike single biofilm cultures, 
indicating different dominant mechanisms at play in a multi-species environment.
It was interesting to note that the trehalose utilisation operon, which provides a growth advantage to 
C. difficile against other gut bacteria72, was upregulated in both the single luxS biofilms (Table 1) and luxS 
co-cultured with B. fragilis (Table 3). The upregulation of a phosphotransferase system component and treA 
(both in the same operon), likely enables increased utilisation of trehalose, providing an additional carbon 
source. Like glucose, trehalose acts as an osmoprotectant73 and its presence within the cell may help maintain 
protein conformation during cellular dehydration. It is possible that trehalose plays a role in building C. difficile 
biofilms, as reported for Candida biofilms74. Our preliminary studies with exogenous trehalose levels similar 
No Gene ID log2FoldChange Gene Annotation
1 CDR20291_0491 1.0964355 RNA methylase
2 CDR20291_0492 1.1802034 hypothetical protein
3 CDR20291_0493 1.0076105 outer membrane lipoprotein
4 CDR20291_0715 1.6245725 N-acetylmuramoyl-L-alanine amidase
5 CDR20291_1366 0.9274027 ferrous ion transport protein
6 CDR20291_1374 1.1651176 iron-sulfur protein
7 CDR20291_1691 1.4187304 nitrite and sulfite reductase subunit
8 CDR20291_1716 1.3143654 thiol peroxidase
9 CDR20291_1717 1.110872 hypothetical protein
10 CDR20291_1934 1.5456229 hypothetical protein
11 CDR20291_1936 1.3368874 GntR family transcriptional regulator
12 CDR20291_1937 1.3736945 ABC transporter ATP-binding protein
13 CDR20291_2389 1.2619709 competence protein
14 CDR20291_2830 1.11333 ribonucleoside-diphosphate reductase subunit alpha
15 CDR20291_2928 1.7538156 PTS system transporter subunit IIABC
16 CDR20291_2930 1.5713168 trehalose-6-phosphate hydrolase
17 CDR20291_3075 1.3649687 osmoprotectant ABC transporter substrate-binding/permease
18 CDR20291_3104 0.8099098 sigma-54-dependent transcriptional activator
19 CDR20291_3434 1.4402419 homocysteine S-methyltransferase
20 CDR20291_0025 −1.32053 acetoin:2%2C6-dichlorophenolindophenol oxidoreductase subunit alpha
21 CDR20291_0615 −0.86915 nucleotide phosphodiesterase
22 CDR20291_0802 −2.260047 ABC transporter substrate-binding protein
23 CDR20291_0911 −1.24181 electron transfer flavoprotein subunit beta
24 CDR20291_1359 −0.850952 hypothetical protein
25 CDR20291_1370 −1.124726 tyrosyl-tRNA synthetase
26 CDR20291_1497 −1.456296 phosphomethylpyrimidine kinase
27 CDR20291_1498 −1.727285 hydroxyethylthiazole kinase
28 CDR20291_1499 −1.276387 thiamine-phosphate pyrophosphorylase
29 CDR20291_1591 −1.51799 dinitrogenase iron-molybdenum cofactor
30 CDR20291_1901 −1.832663 ABC transporter ATP-binding protein
31 CDR20291_1902 −1.875507 ABC transporter substrate-binding protein
32 CDR20291_1903 −1.659329 ABC transporter permease
33 CDR20291_1904 −1.638609 hypothetical protein
34 CDR20291_1925 −1.54806 flavodoxin
35 CDR20291_2474 −1.434272 DNA-directed RNA polymerase subunit omega
36 CDR20291_2515 −1.603951 amino acid permease family protein
37 CDR20291_2516 −1.176482 cobalt dependent x-pro dipeptidase
38 CDR20291_2660 −0.958814 teichuronic acid biosynthesis glycosyl transferase
39 CDR20291_2870 −2.335518 hypothetical protein
40 CDR20291_3142 −1.665916 pyrroline-5-carboxylate reductase
41 CDR20291_3143 −1.830481 formate acetyltransferase
42 CDR20291_3144 −1.643573 pyruvate formate-lyase 3 activating enzyme
Table 3. Genes up and down-regulated in luxS during co-culture with B. fragilis relative to the WT C. difficile 
monoculture. Note: P-adjusted value ≤ 0.05.
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to those used by Collins et al. (2018) showed an inhibitory effect on biofilm formation by both WT C. difficile 
and luxS, although no differential effects were observed between luxS and WT (Fig. S9). However, further 
investigations into accumulation of trehalose within biofilms are required to clarify the role of trehalose in luxS 
mediated biofilm formation.
In conclusion, we report that C. difficile LuxS/AI-2 may play a key role in building C. difficile communities 
through mediating prophage induction, and subsequent accumulation of eDNA. In mixed communities, C. dif-
ficile AI-2 likely signals to B. fragilis to induce an altered metabolic response, enabling it to outgrow C. difficile. 
Further studies are required to understand the precise AI-2 sensing pathways involved.
Materials and Methods
Bacterial strains and media. Two bacterial species were used in this study – C. difficile strain: B1/
NAP1/027 R20291 (isolated from the Stoke Mandeville outbreak in 2004 and 2005), and Bacteroides fragilis (a 
clinical isolate from a biliary stent kindly provided by Dr Claudia Vuotto and Dr Gianfranco Donelli, Rome). A 
luxS Clostron R20291 mutant described previously in Dapa et al.27 was used in this study. Both species were cul-
tured under anaerobic conditions (80% N2, 10% CO2, 10% H2) at 37 °C in an anaerobic workstation (Don Whitley, 
United Kingdom) in BHIS, supplemented with L-Cysteine (0.1% w/v; Sigma, United Kingdom), yeast extract 
(5 g/l; Oxoid) and glucose (0.1 M).
Vibrio harveyi strain: BB170 was used to measure AI-2. V. harveyi strains were cultured in aerobic conditions 
at 30 °C in Lysogeny broth (LB) supplemented with kanamycin (50 µg/ml).
Biofilm formation assay. Biofilms were grown as per the previously published protocol27. Overnight cul-
tures of C. difficile were diluted 1:100 in fresh BHIS with 0.1 M glucose. 1 ml aliquots were pipetted into 24-well 
tissue culture treated polystyrene plates (Costar), and incubated under anaerobic condition at 37 °C, for 6–120 h. 
Tissue culture plates were pre-incubated for 48 h prior to use. The plates were wrapped with parafilm to prevent 
liquid evaporation.
Measurement of biofilm biomass. Biofilm biomass was measured using crystal violet (CV)27. After the 
required incubation, each well of the 24-well plate was washed with sterile phosphate buffer saline (PBS) and 
allowed to dry for a minimum of 10 mins. The biofilm was stained using 1 ml of filter-sterilised 0.2% CV and 
incubated for 30 mins at 37 °C, in anaerobic conditions. The CV was removed from each well, and wells were 
subsequently washed twice with sterile PBS. The dye was extracted by incubated with 1 ml methanol for 30 mins 
at room temperature in aerobic conditions. The methanol-extracted dye was diluted 1:1, 1:10 or 1:100 and OD570 
was measured with a spectrophotometer (BMG Labtech, UK).
For bacterial cell counts from the biofilm, the planktonic phase was removed and wells were washed 
once using sterile PBS. The adherent biofilms were then detached by scrapping with a sterile pipette tip and 
re-suspended into 1 ml PBS. Serial dilutions were made and plated onto BHIS plates to determine the CFU pres-
ent in the biofilm.
Co-culture biofilm assay. For generation of co-culture biofilms, both C. difficile and B. fragilis were diluted 
to an OD600 of 1. Both species were diluted 1:100 into fresh BHIS with 0.1 M glucose. Biofilms assays were per-
formed as described above and measured by a combination of CV staining and CFU. To distinguish between C. 
difficile and B. fragilis, serial dilutions used for determining CFU were plated on BHIS plates additionally sup-
plemented with C. difficile selective supplement (Oxoid, UK). Colonies can be differentiated by size and colony 
morphology as B. fragilis form very small colonies.
exogenous addition of DpD. To analyse the potential signalling role of AI-2, biofilm assays were per-
formed as described above in BHIS with 0.1 M glucose containing 1 nM, 10 nM, 100 nM, or 1 µM of chemically 
synthesised, exogenous 4,5-Dihydroxy-2,3-pentanedione (Omm Scientific, Texas USA) for both C. difficile WT 
and LuxS. BHIS with 0.1 M glucose was used as a control. Samples were washed and stained with 0.2% CV at 
either 24 h or 72 h.
AI-2 Assay. The AI-2 bioluminescence assay was carried out essentially as described by Bassler et al. 199375. 
The V. harveyi reporter strain BB170 was grown overnight in LB medium before being diluted 1: 5000 in 
Autoinducer Bioassay (AB) medium containing 10% (v/v) cell-free conditioned medium collected from either 
planktonic or biofilm C. difficile cultures (in BHI) and allowed to grow at 30 °C with shaking. AB medium con-
taining 10% (v/v) from V. harveyi BB120 was used as a positive control, and 10% (v/v) sterile BHI medium as a 
blank. Luminescence was measured every hour using a SPECTROstar Omega plate reader. Induction of lumi-
nescence was taken at the time when there was maximal difference between the positive and negative controls 
(usually 2–5 h) and is expressed as a percentage of the induction observed in the positive control.
RNA-seq. Biofilms were grown for 18 h in BHIS + glucose, supernatants were removed and attached biofilms 
were washed with 1 ml PBS. Biofilms were disrupted and RNA was extracted using Trizol (Invitrogen, UK). 5 µg of 
extracted RNA was treated with RiboZEROTM (Illumina, UK) according to the manufacturer’s protocol to deplete 
rRNA. cDNA libraries were prepared using TruSEQ LT (Illumina, UK) according to the manufacturer’s instruc-
tions. Briefly, samples were end-repaired, mono-adenylated, ligated to index/adaptors. Libraries were quantified 
by bioanalyzer and fluorometer assay. The final cDNA library was prepared to a concentration of 10–12 pM and 
sequenced using paired end technology using a version-3 150-cycle kit on an Illumina MiSeqTM (Illumina, UK).
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RNA-seq analysis. The paired-end sequencing reads from RNA-seq experiments were mapped against the 
appropriate reference genome (NC_013316 for C. difficile and a de novo assembly using RNA SPAdes v3.9 with 
default settings76 from the RNA-sequence reads for B. fragilis [Accession number PRJEB29695). The first read was 
flipped into the correct orientation using seqtk v1.3 (https://github.com/lh3/seqtk) and the reads were mapped 
against the reference genome using BWA v0.7.5 with the ‘mem’ alignment algorithm77. BAM files were manipu-
lated with Samtools v0.1.18 using the ‘view’ and ‘sort’ settings77. Sorted BAM and GFF (general feature format) 
files were inputted into the coverageBed tool v2.27.0 with default settings78 to gain abundance of each genomic 
feature. The R package DESeq2 was used with default settings to calculate differential gene expression using 
a negative binomial distribution model42. The data was filtered by applying a cut-off of 1.6 for the fold change 
and 0.05 for the adjusted p-value. All sequencing reads were submitted to the European Bioinformatics Institute 
(Accession numbers E-MTAB-7486, E-MTAB-7523 and PRJEB29695).
As analysis by BLAST (NCBI) demonstrated species specificity for mapping, co-culture samples were mapped 
to each species reference separately. Initial mapping of the B. fragilis strain to a published reference proved unsuc-
cessful, offering a poor rate of alignment of 60%. As the B. fragilis strain has not been previously sequenced, and 
because we were not successful in generating high quality genome sequence, a reference was generated from RNA 
library of B. fragilis using the software rnaSPAdes v3.979 and annotated using Prokka v1.11 (default settings)80. The 
reads from each condition were mapped to their respective reference sequence using BWA v0.7.5 (‘mem’ algo-
rithm)77,81 and counted using coverageBed v2.27.078. Metabolic pathways in C. difficile were identified using the 
KEGG mapper82, a tool that identifies the function of genes in a published genome. As the B. fragilis strain used 
in this study does not have a published reference genome, blastKOALA83 was used to search for gene homology 
within metabolic pathways. Heatmaps were generated from normalised gene expression data outputted from 
DESeq2, using the online tool Heatmapper84 using the default settings.
pCR analysis. 16S PCRs were performed using the universal 16S rRNA bacterial primers 27F and 1392R 
(Table S2). Primers were constructed for prophage genes CDR20219_1208 and CDR20291_1436 (Table S2) to 
confirm the presence of prophage within C. difficile biofilms. PCR was carried out using Fusion High-Fidelity 
DNA polymerase (NEB, USA) following the manufacturer’s protocol. Samples were heated to 95 °C for 5 mins 
followed by 35 cycles of: 95 °C for 30 seconds, 51 °C for 30 seconds and 72 °C for 30 seconds, after which samples 
were heated to 72 °C for 10 mins.
eDNA quantification. eDNA was extracted from C. difficile biofilms grown in a 24-well plate as described 
above, using a protocol described in Rice et al.53. Briefly, the plate was sealed with parafilm and chilled at 4 °C 
for 1 hour. 1 μl 0.5 M EDTA was added to each well and incubated at 4 °C for 5 mins. The medium was removed 
and biofilms were resuspended in 300 μl 50 mM TES buffer (50 mM Tris HCl/10 mM EDTA/500 mM NaCl). The 
OD600 was measured to determine biofilm biomass and the tubes were centrifuged at 4 °C at 18,000 g for 5 mins, 
and was used to normalise the eDNA values. 100 μl of supernatant was transferred to a tube of chilled TE buffer 
(10 mM Tris HCl/ 1 mM EDTA) on ice. DNA was extracted using an equal volume of phenol/chloroform/isoamyl 
alcohol three times. 3 volumes of ice-cold 100% ethanol and 1/10 volumes 3 M sodium acetate were added to the 
aqueous phase to precipitate the DNA. The DNA pellet was washed with 1 ml ice-cold 70% ethanol, dissolved in 
20 μl TE buffer, quantified by Qubit fluorometer (Thermo Fisher).
spore counts. To determine the number of spores, adherent biofilms were resuspended in PBS and treated at 
65 °C for 25 mins as previously described85. Untreated and heat-treated samples were serial diluted and plated on 
BHIS and BHIS-TC agar (supplemented with 0.1% sodium taurocholate, Sigma-Aldrich, UK). No bacteria were 
obtained from the heat-treated samples plated on BHI (without sodium taurocholate). The CFU/ml obtained 
from heat-treated samples plated on BHIS-TC plates represent heat-resistant spores, and the CFU/ml obtained 
from untreated samples plated on BHIS plates represent the total cell counts.
statistical analysis. All experiments were performed in triplicate, with at least three independent exper-
iments performed. Paired or unpaired student’s t-test was used to determine if differences between two groups 
were significant, and one way-ANOVA was used to compare multiple groups. Mann-Whitney U tests were used 
to compare non-parametric data. Fisher’s exact t-test was used to confirm the enrichment of differently regulated 
genes in prophage regions.
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